Context Therapeutics Inc.
CNTX
NASDAQ·Healthcare·Biotechnology·Mkt cap $33.2M
$0.36
▼ -0.36%
P/E
—
Mkt Cap
$33.2M
52-Wk Range
$0.35–$3.62
52-Week Range
$0.35 - $3.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 56.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary selective progesterone receptor antagonist technology with extended-release formulation
- Strategic collaboration with Integral Molecular for bispecific antibody development
- Focused pipeline targeting underserved women's oncology market with high unmet medical need
- Novel mechanism of action addressing therapeutic resistance in multiple cancer types
Bear Case
1 risk
- Above-average volatility (beta 1.7).
Growth
Stable outlook
Progression of ONA-XR through clinical development and potential FDA approval pathways
Value
Valuation data unavailable
Momentum
Falling
-78.8% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying CNTX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of -$0.15 vs -$0.09 consensus (-62.8% surprise).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-62.8%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
5 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 6, 2026
vs Industry
How CNTX stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related